Letters: Regulate genetic testing

Although the technology is amazing, we need to regulate its use, like the dosage for any medicine

Image
Business Standard
Last Updated : Feb 19 2017 | 10:36 PM IST
With reference to Devangshu Datta’s column, “The ethics of editing genes” (February 17), helping to eliminate the pain and suffering that comes with genetic disorders — for example, Huntington’s disease — is as big a step forward as discovering a vaccine or eliminating diseases such as smallpox.

Although the technology is amazing, we need to regulate its use, like the dosage for any medicine. The potential implications of CRISPR and gene editing overall are huge and difficult to predict. Biosecurity experts predict doomsday scenarios, where gene drives inserted into insects could spread lethal diseases or kill insects needed for pollinating crops.

Experts at a recent Washington summit took the correct stand that altering DNA of human embryos for clinical purposes is unacceptable given unknown risks today. On the other hand, progress of advances that could eradicate genetic diseases should not be halted.

Genetic testing, however, raises inconvenient ethical questions. It has the potential to control humanity, with some authoritarian regimes suspected to be looking at breeding superior races. It can modify people in ways that would help in controlling them. When Francis Galton put forward the theory of eugenics, he said, “Humanity shall be represented by the fittest races.” The flip side of CRISPR/genetic testing has the same potential.

H N Ramakrishna, Bengaluru


Letters can be mailed, faxed or e-mailed to:
The Editor, Business Standard
Nehru House, 4 Bahadur Shah Zafar Marg
New Delhi 110 002
Fax: (011) 23720201  ·  E-mail: letters@bsmail.in
All letters must have a postal address and telephone number

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Next Story